An NCI-designated Comprehensive Cancer Center

City Stories

Microbes in Space | City of Hope
Cancer care predictions 2020:
The best is yet to come
January 7, 2020 | By Abe Rosenberg
City of Hope clinicians and researchers are brimming with optimism as 2020 begins. Cancer care is changing rapidly, and the pace of change is accelerating. In 2020 look for major advances in gene-based therapy, immunotherapy and many other areas.
Research | Patient Care
Feldman and Badie Thumbnail
Rescue Mission
January 8, 2020 | By Stephanie Smith
Inside CAR T Brain Surgery
Raspberry Tart with Chocolate
Rustic Spiced Raspberry Tart with Chocolate
February 11, 2020 | By Malcolm Bedell
This Valentine’s Day, consider skipping the expensive night out, or the overly-complicated home-cooked meal, and focus on a project you can do together, as a couple.
Recipes | All Topics
Breakthroughs - Stephen Forman 256x256
City of Hope's BMT survival rates exceed expectations for 15 consecutive years
February 14, 2020 | By City of Hope
City of Hope’s bone marrow transplantation program has achieved a higher-than-expected survival rate based on a 2019 analysis by the Center for International Blood and Marrow Transplant Research.
Hematologic Malignancies | Treatments | Clinical Trials
Weitzel 256x256
$8.5M grant fuels research into rare genetic disorder
January 10, 2020 | By Letisia Marquez
The National Institutes of Health funding will support a City of Hope study of a rare cancer-causing syndrome linked to an inherited mutation in the TP53 gene. Li-Fraumeni syndrome causes various cancers early in life.
Clinical Trials/Studies

Breakthroughs

Time Series of Microtentacles on a Breast Cancer Cell | City of Hope
Could targeting your
internal clock be key
to slowing cancer?
February 19, 2020 | By Zen Vuong
Using models, City of Hope scientists identified a defective part of the circadian rhythm gene that may result in accelerated breast cancer progression in obese, prediabetic people.
Research
Beckman Research Institute exterior
New grad school deans
share ambitious vision
February 18, 2020 | By Samantha Bonar
Two new deans, David Ann, Ph.D., and Yilun Liu, Ph.D., have taken the helm of City of Hope’s graduate program, determined to attract the best and brightest students from around the nation and the globe.
Research | Education
Breakthroughs - gallbladder and bile duct cancers treatments
New hope for two
of the deadliest cancers
February 17, 2020 | By Maxine Nunes
During awareness month for the diseases, City of Hope specialists discuss the latest developments in the understanding and treatment of rare and aggressive gallbladder and bile duct cancer.
Patient Care

Hopeful

Raspberry Tart with Chocolate
Rustic Spiced Raspberry Tart with Chocolate
This Valentine’s Day, consider skipping the expensive night out, or the overly-complicated home-cooked meal, and focus on a project you can do together, as a couple.
Recipes | All Topics
Tortellini
Spinach Tortellini en Brodo
This spinach tortellini en brodo recipe is packed with fresh spinach, which has several potential cancer-fighting effects. Spinach is loaded with vitamin C and beta carotene, which according to the National Institutes of Health, may help protect against certain kinds of cancer.
All Topics | Recipes
Anal Cancer
What You Need to Know About Anal Cancer
While anal cancer is rare, we can’t turn a blind eye to it. You may feel that talking about anal cancer is uncomfortable, but it’s time to end the stigma and shame surrounding this disease.
Lifestyle | All Topics

Physician News

Breakthroughs - Dr. Trisal and patient - 256x256
City of Hope Receives Two Press Ganey Awards for Exceptional Patient Care
February 14, 2020 | By City of Hope
City of Hope has recently received two national awards for excellence in inpatient care from Press Ganey — the 2019 Guardian of Excellence Award and the 2019 Pinnacle of Excellence Award. The Guardian of Excellence Award recognizes top-performing health care organizations that have consistently achieved the 95th percentile or above for inpatient satisfaction. The Pinnacle of Excellence Award recognizes institutions that maintain consistently high levels of excellence across three years in patient experience.
Thought Leaders
Breakthroughs - Stephen Forman 256x256
City of Hope's BMT survival rates exceed expectations for 15 consecutive years
February 14, 2020 | By City of Hope
City of Hope’s bone marrow transplantation program has achieved a higher-than-expected survival rate based on a 2019 analysis by the Center for International Blood and Marrow Transplant Research.
Hematologic Malignancies | Treatments | Clinical Trials
breakthroughs - t cells
New Immunotherapy Research Presented at ASH Annual Meeting 2019
December 30, 2019 | By City of Hope
Novel research findings on promising therapeutic approaches in lymphoma, myeloma and leukemia were presented by several City of Hope investigators during the ASH annual meeting in Orlando.
Clinical Trials

Research News

Weitzel 256x256
$8.5M grant fuels research into rare genetic disorder
January 10, 2020 | By Letisia Marquez
The National Institutes of Health funding will support a City of Hope study of a rare cancer-causing syndrome linked to an inherited mutation in the TP53 gene. Li-Fraumeni syndrome causes various cancers early in life.
Clinical Trials/Studies
brain tumor
New immunotherapy trial targets recurrent glioblastoma
January 10, 2020 | By Letisia Marquez
City of Hope has opened a first-in-human clinical trial for patients with recurrent glioblastoma. To launch the randomized trial, the National Institutes of Health awarded $3.3 million over five years to Behnam Badie, M.D. and Christine Brown, Ph.D. Brown and Badie also received $800,000 from Gateway for Cancer Research.
Clinical Trials/Studies
Chen-Shiuan
Chen Receives $3.3M Grant
for Prostate Mushroom Study
January 9, 2020 | By C. Pete Lee
Shiuan Chen, Ph.D., who heads City of Hope’s Natural Therapies Program, is studying the effects of white button mushrooms on prostate cancer patients. He previously found that phytochemicals in mushrooms had the ability to block the activity of an enzyme that contributes to breast cancer.
Clinical Trials/Studies